Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. “Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.” 2017 Dec 6:0. doi: 10.5301/tj.5000702. [Epub ahead of print]
Aksu, G., M. Fayda, B. Sakar ve Y. Kapran, “Colon cancer with isolated metastasis to the kidney at time of initial diagnosis. A case report”, International Journal of Gastrointestinal Cancer, 34(2-3), 73-7 (2003)
Kaytan, E., A. Karadeniz, S. Alıcı, M. Fayda ve A. Kizir, “Unusual metastases from rectal adenocarcinoma; report of two cases with literature review”, Journal of BUON, 7(4), 377-80 (2002)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015
Almaç, Z., M. Fayda, O. Asoğlu, S. Sağlam, S. Yücel, H. Acun, E. Saglam, A. Kizir, H. Camlıca ve E.N. Oral, “Early results of neoadjuvant hyperfractionated accelarated radiotherapy (HART) with concurrent and postoperative chemotherapy for locally advanced rectal cancer”, Int J Radiat Oncol Biol Phys Supplement, 78 (3), sayfa: 300 (2010).
Dagoglu, N., S. Karaman, B. Sakallioglu, M. Fayda, S. Saglam, B. Sakar, O. Asoglu, E. Balik, E. Kaytan Saglam, H. Camlıca, A. Kizir ve E. N. Oral, “Neoadjuvant chemoradiotherapy for T3-4N0+ rectal carcinoma”, 29th Annual ESTRO Meeting 12-16 September Barcelona 2010.
Aksu, G., M. Fayda, B. Sakar ve Y. Kapran, “Colon cancer with isolated metastasis to the kidney at time of initial diagnosis. A case report”, International Journal of Gastrointestinal Cancer, 34(2-3), 73-7 (2003)
Kaytan, E., A. Karadeniz, S. Alıcı, M. Fayda ve A. Kizir, “Unusual metastases from rectal adenocarcinoma; report of two cases with literature review”, Journal of BUON, 7(4), 377-80 (2002)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015
Almaç, Z., M. Fayda, O. Asoğlu, S. Sağlam, S. Yücel, H. Acun, E. Saglam, A. Kizir, H. Camlıca ve E.N. Oral, “Early results of neoadjuvant hyperfractionated accelarated radiotherapy (HART) with concurrent and postoperative chemotherapy for locally advanced rectal cancer”, Int J Radiat Oncol Biol Phys Supplement, 78 (3), sayfa: 300 (2010).
Dagoglu, N., S. Karaman, B. Sakallioglu, M. Fayda, S. Saglam, B. Sakar, O. Asoglu, E. Balik, E. Kaytan Saglam, H. Camlıca, A. Kizir ve E. N. Oral, “Neoadjuvant chemoradiotherapy for T3-4N0+ rectal carcinoma”, 29th Annual ESTRO Meeting 12-16 September Barcelona 2010.